Innovative imaging can enhance our understanding of pulmonary vascular disease mechanisms, refine classification, improve outcomes by reducing time to diagnosis, aid treatment decision-making and provide a holistic approach to assess impact to therapies. bit.ly/3RvMWTQ

Thanks to Sandeep Sahay, MD, MSc, ATSF, for his contribution to the September 1 issue Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective Sandeep Sahay, MD, MSc Vallerie McLaughlin atsjournals.org/doi/full/10.11…

Today marks the birthday anniversary of Michael DeBakey (1908-2008), a pioneering cardiovascular surgeon who transformed heart surgery with breakthroughs like arterial bypasses, artificial hearts, and transplants.

Cardiopulmonary haemodynamics assessed by right heart catheterisation improve risk stratification at follow-up in patients with pulmonary arterial hypertension at intermediate-low or intermediate-high risk according to the non-invasive four-strata tool bit.ly/4bd0ScP

Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome Impaired BMP-9 signaling in the lungs, triggered by cirrhosis or noncirrhotic portal hypertension, contributes to the development of hepatopulmonary syndrome 🔗 tinyurl.com/mrnvkdcu

🔴 J3 [#ERSCongress] : hot topics in pulmonary hypertension - le Pr Olivier Sitbon présente les dernières mises à jour de l’algorithme de prise en charge des patients atteints d’#HTAP, ainsi que l’évolution de l’arsenal thérapeutique disponible pour ces patients !

How I Do It: Using Sotatercept in the Care of Patients With Pulmonary Arterial Hypertension Read the full pulmonary vascular research from the September CHEST® Journal issue to learn more: hubs.la/Q02PdJ-q0 #MedEd #MedTwitter #PAH

The Blue Journal thanks Fabien Robert, PharmD, MSc, for his contribution to the September 1 issue Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome atsjournals.org/doi/full/10.11…

What a great congress! Thank you everyone that attended the PVD and PE sessions. Yesterday, we had a fantastic assembly meeting! Stay tuned for what's coming next.

Happening next month, 'Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights' is the first webinar in the NEW High Altitude Task Force series. 1 October 1pm BST, register for free us02web.zoom.us/webinar/regist…

📣 📣Calling all #PH #PVD enthusiasts - don’t miss our “Best of ATS PC Assembly at #ATS2024” webinar on Oct. 8th! Assemblies of American Thoracic Society ATS Early Career Vinicio de Jesus Perez, MD FAHA FCCP ATSF Rebecca Vanderpool, PhD Stephen Chan Soban Umar, MD, PhD, FAHA, ATSF 🫁🫀 Pullamsetti Lab Sandeep Sahay, MD, MSc Roberto J. Bernardo, MD, MS, ATSF 🇵🇪🇺🇸 Register here: thoracic.zoom.us/meeting/regist…

Contemporary Treatment of Pulmonary Arterial Hypertension: A US Perspective Sandeep Sahay, MD, MSc Vallerie McLaughlin U-M Health Frankel CVC Houston Methodist American Thoracic Society (ATS) 🔗 tinyurl.com/t9bkfzsj

Wow! Boehringer-Ingelheim announces that Nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study - a decade after the first positive phase III trials for IPF. Cannot wait to see the full results but this EXCITING !!! #CureIPF boehringer-ingelheim.com/us/topline-res…

The Aristotle Classes on PH & ACHD is a scientific event organised jointly by the Medical School of Aristotle University, the Heart Center at Universität zu Köln, and Royal Brompton and Harefield. The programme will feature: • state of the Art interactive plenary sessions • abstract presentations •

Cardiology and Pulmonary Fellows interested in Pulmonary Vascular Disease: The UCLA PVD Program is excited to offer a one year advanced fellowship, starting July 2025! See attached description and we look forward to hearing from you! Richard Channick, M.D. and Rajan Saggar

💗to announce we have just received an $8.7 Million NIH grant to study arrhythmic mitral valve prolapse using cardiac MRI! We are recruiting for research scholars interested in joining our group to help us better understand this condition. Society for Cardiovascular Magnetic Resonance American Society of Echocardiography NIH Funding

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2) sciencedirect.com/science/articl…

Thanks to all patients worldwide who participated in this negative study and kudos to all the investigators and trial leadership to publish a negative study. Olivier Sitbon Vallerie McLaughlin Ardeschir Ghofrani ATS PC Assembly CHEST Pulmonary Vascular and Cardiovascular ERS_PVD_Assembly_13 ERS

Positive phase 3 trial in IPF : awaited for the past 10 years. A major step forward in the field. Congratulations on behalf of the whole ILD community. Stay tuned for more information with the publication to come

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia | New England Journal of Medicine nejm.org/doi/full/10.10…